Cargando…
Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations
BACKGROUND: The COVID-19 pandemic can exacerbate underlying substance use disorder and has impacted this vulnerable population in a variety of ways. There are limited data regarding how this pandemic has impacted emergency department (ED) patient presentations. METHODS: We extracted data on ED visit...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387574/ https://www.ncbi.nlm.nih.gov/pubmed/34509745 http://dx.doi.org/10.1016/j.ajem.2021.08.058 |
_version_ | 1783742470048186368 |
---|---|
author | Chandran, Kira Mazer-Amirshahi, Maryann Shankar, Nikash Desale, Sameer Nelson, Lewis Mete, Mihriye |
author_facet | Chandran, Kira Mazer-Amirshahi, Maryann Shankar, Nikash Desale, Sameer Nelson, Lewis Mete, Mihriye |
author_sort | Chandran, Kira |
collection | PubMed |
description | BACKGROUND: The COVID-19 pandemic can exacerbate underlying substance use disorder and has impacted this vulnerable population in a variety of ways. There are limited data regarding how this pandemic has impacted emergency department (ED) patient presentations. METHODS: We extracted data on ED visits from the electronic health record (EHR) of a large healthcare system in the Washington, DC/Baltimore, MD metropolitan area. The dataset includes data from 7 hospitals on ED visits between 11/1/2019–6/30/2020. The health system utilizes a validated screening program for substance use, Screening, Brief Intervention, and Referral to Treatment (SBIRT), for ED patients who are clinically stable and willing to complete screening. We evaluated trends in patients with a positive SBIRT screen and those presenting with a clinical diagnosis of acute alcohol or substance intoxication/overdose before (11/1/19–2/29/2020-pre) and during the first wave of the COVID pandemic (3/1/2020–6/30/2020-post). Data were described using descriptive statistics. Bivariate analyses were conducted using chi-square test and two-sample t-tests. Interrupted time series analysis was used to evaluate the changes in the weekly trends with the start of the pandemic. RESULTS: There were 107,930 screens performed in the EDs during the study period (61,961 pre, 45,969 post). The population was primarily African American (64.7%) and female (57.1%). Positive SBIRT screens increased from 12.5% to 15.8% during COVID (p < 0.001). Alcohol intoxication presentations increased as a proportion of positive screens from 12.6% to 14.4% (p = 0.001). A higher percentage of screened patients reported problem drinking (AUDIT score ≥ 7) during the pandemic (2.4% pre vs 3.2% post, p < 0.001). Substance intoxication/overdoses among all screened increased from 2.1% to 3.1% (p < 0.001) and as a percentage of positive screens during the pandemic (16.8% to 20%, p < 0.001). The proportion of opioid vs. non-opioid overdoses remained unchanged before (67%) and during the pandemic (64%, p = 0.33). DISCUSSION: There was an increase in the proportion of positive SBIRT screens and visits for acute overdoses and intoxication during the first wave of the COVID-19 pandemic. Additional research should focus on mitigation strategies to address substance use during this vulnerable time. |
format | Online Article Text |
id | pubmed-8387574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83875742021-08-26 Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations Chandran, Kira Mazer-Amirshahi, Maryann Shankar, Nikash Desale, Sameer Nelson, Lewis Mete, Mihriye Am J Emerg Med Article BACKGROUND: The COVID-19 pandemic can exacerbate underlying substance use disorder and has impacted this vulnerable population in a variety of ways. There are limited data regarding how this pandemic has impacted emergency department (ED) patient presentations. METHODS: We extracted data on ED visits from the electronic health record (EHR) of a large healthcare system in the Washington, DC/Baltimore, MD metropolitan area. The dataset includes data from 7 hospitals on ED visits between 11/1/2019–6/30/2020. The health system utilizes a validated screening program for substance use, Screening, Brief Intervention, and Referral to Treatment (SBIRT), for ED patients who are clinically stable and willing to complete screening. We evaluated trends in patients with a positive SBIRT screen and those presenting with a clinical diagnosis of acute alcohol or substance intoxication/overdose before (11/1/19–2/29/2020-pre) and during the first wave of the COVID pandemic (3/1/2020–6/30/2020-post). Data were described using descriptive statistics. Bivariate analyses were conducted using chi-square test and two-sample t-tests. Interrupted time series analysis was used to evaluate the changes in the weekly trends with the start of the pandemic. RESULTS: There were 107,930 screens performed in the EDs during the study period (61,961 pre, 45,969 post). The population was primarily African American (64.7%) and female (57.1%). Positive SBIRT screens increased from 12.5% to 15.8% during COVID (p < 0.001). Alcohol intoxication presentations increased as a proportion of positive screens from 12.6% to 14.4% (p = 0.001). A higher percentage of screened patients reported problem drinking (AUDIT score ≥ 7) during the pandemic (2.4% pre vs 3.2% post, p < 0.001). Substance intoxication/overdoses among all screened increased from 2.1% to 3.1% (p < 0.001) and as a percentage of positive screens during the pandemic (16.8% to 20%, p < 0.001). The proportion of opioid vs. non-opioid overdoses remained unchanged before (67%) and during the pandemic (64%, p = 0.33). DISCUSSION: There was an increase in the proportion of positive SBIRT screens and visits for acute overdoses and intoxication during the first wave of the COVID-19 pandemic. Additional research should focus on mitigation strategies to address substance use during this vulnerable time. Elsevier Inc. 2021-12 2021-08-26 /pmc/articles/PMC8387574/ /pubmed/34509745 http://dx.doi.org/10.1016/j.ajem.2021.08.058 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Chandran, Kira Mazer-Amirshahi, Maryann Shankar, Nikash Desale, Sameer Nelson, Lewis Mete, Mihriye Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations |
title | Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations |
title_full | Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations |
title_fullStr | Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations |
title_full_unstemmed | Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations |
title_short | Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations |
title_sort | impact of covid-19 pandemic on emergency department substance use screens and overdose presentations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387574/ https://www.ncbi.nlm.nih.gov/pubmed/34509745 http://dx.doi.org/10.1016/j.ajem.2021.08.058 |
work_keys_str_mv | AT chandrankira impactofcovid19pandemiconemergencydepartmentsubstanceusescreensandoverdosepresentations AT mazeramirshahimaryann impactofcovid19pandemiconemergencydepartmentsubstanceusescreensandoverdosepresentations AT shankarnikash impactofcovid19pandemiconemergencydepartmentsubstanceusescreensandoverdosepresentations AT desalesameer impactofcovid19pandemiconemergencydepartmentsubstanceusescreensandoverdosepresentations AT nelsonlewis impactofcovid19pandemiconemergencydepartmentsubstanceusescreensandoverdosepresentations AT metemihriye impactofcovid19pandemiconemergencydepartmentsubstanceusescreensandoverdosepresentations |